Tradewinds Capital Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $47.6K | Hold |
1,976
| – | – | 0.01% | 225 |
|
|
2026
Q1 | $55.5K | Hold |
1,976
| – | – | 0.01% | 202 |
|
|
2025
Q4 | $49.2K | Sell |
1,976
-120
| -6% | -$3.03K | 0.01% | 213 |
|
|
2025
Q3 | $53.4K | Hold |
2,096
| – | – | 0.01% | 196 |
|
|
2025
Q2 | $50.8K | Sell |
2,096
-355
| -14% | -$8.28K | 0.01% | 191 |
|
|
2025
Q1 | $62.1K | Buy |
2,451
+574
| +31% | +$15K | 0.02% | 177 |
|
|
2024
Q4 | $49.8K | Buy |
1,877
+46
| +3% | +$1.25K | 0.01% | 203 |
|
|
2024
Q3 | $53K | Buy |
1,831
+1
| +0.1% | +$29 | 0.01% | 184 |
|
|
2024
Q2 | $51.2K | Sell |
1,830
-500
| -21% | -$13.8K | 0.02% | 177 |
|
|
2024
Q1 | $64.7K | Buy |
2,330
+500
| +27% | +$13.9K | 0.02% | 144 |
|
|
2023
Q4 | $52.7K | Sell |
1,830
-25
| -1% | -$756 | 0.02% | 121 |
|
|
2023
Q3 | $61.5K | Hold |
1,855
| – | – | 0.02% | 105 |
|
|
2023
Q2 | $68K | Buy |
1,855
+18
| +1% | +$701 | 0.02% | 109 |
|
|
2023
Q1 | $75K | Sell |
1,837
-40
| -2% | -$1.73K | 0.02% | 96 |
|
|
2022
Q4 | $96.2K | Buy |
1,877
+47
| +3% | +$2.25K | 0.04% | 65 |
|
|
2022
Q3 | $80K | Sell |
1,830
-320
| -15% | -$15.6K | 0.03% | 74 |
|
|
2022
Q2 | $113K | Sell |
2,150
-4,427
| -67% | -$226K | 0.04% | 60 |
|
|
2022
Q1 | $340K | Sell |
6,577
-427
| -6% | -$22.2K | 0.06% | 88 |
|
|
2021
Q4 | $414K | Buy |
7,004
+85
| +1% | +$4.21K | 0.06% | 85 |
|
|
2021
Q3 | $298K | Sell |
6,919
-267
| -4% | -$11.8K | 0.05% | 88 |
|
|
2021
Q2 | $281K | Sell |
7,186
-1,611
| -18% | -$62.6K | 0.05% | 97 |
|
|
2021
Q1 | $319K | Sell |
8,797
-249
| -3% | -$8.84K | 0.06% | 80 |
|
|
2020
Q4 | $333K | Buy |
9,046
+1,908
| +27% | +$70K | 0.07% | 76 |
|
|
2020
Q3 | $249K | Buy |
7,138
+10
| +0.1% | +$351 | 0.06% | 87 |
|
|
2020
Q2 | $221K | Buy |
7,128
+8
| +0.1% | +$272 | 0.06% | 92 |
|
|
2020
Q1 | $220K | Sell |
7,120
-225
| -3% | -$7.67K | 0.07% | 80 |
|
|
2019
Q4 | $273K | Sell |
7,345
-225
| -3% | -$8.01K | 0.09% | 82 |
|
|
2019
Q3 | $258K | Buy |
7,570
+674
| +10% | +$24.5K | 0.1% | 73 |
|
|
2019
Q2 | $283K | Buy |
6,896
+7
| +0.1% | +$278 | 0.12% | 67 |
|
|
2019
Q1 | $278K | Sell |
6,889
-49
| -0.7% | -$1.96K | 0.1% | 81 |
|
|
2018
Q4 | $287K | Sell |
6,938
-1,307
| -16% | -$54.3K | 0.14% | 71 |
|
|
2018
Q3 | $345K | Buy |
8,245
+290
| +4% | +$11.2K | 0.13% | 69 |
|
|
2018
Q2 | $274K | Sell |
7,955
-1,129
| -12% | -$38.6K | 0.11% | 79 |
|
|
2018
Q1 | $306K | Sell |
9,084
-106
| -1% | -$3.64K | 0.14% | 74 |
|
|
2017
Q4 | $316K | Buy |
9,190
+568
| +7% | +$19.4K | 0.15% | 74 |
|
|
2017
Q3 | $292K | Sell |
8,622
-350
| -4% | -$11.2K | 0.15% | 80 |
|
|
2017
Q2 | $286K | Buy |
8,972
+1,578
| +21% | +$49.8K | 0.15% | 77 |
|
|
2017
Q1 | $240K | Sell |
7,394
-632
| -8% | -$19.9K | 0.15% | 85 |
|
|
2016
Q4 | $247K | Sell |
8,026
-1,719
| -18% | -$52.5K | 0.16% | 80 |
|
|
2016
Q3 | $313K | Buy |
9,745
+1,519
| +18% | +$50.8K | 0.22% | 69 |
|
|
2016
Q2 | $275K | Buy |
8,226
+697
| +9% | +$22.2K | 0.2% | 81 |
|
|
2016
Q1 | $212K | Buy |
7,529
+1,088
| +17% | +$31.1K | 0.14% | 102 |
|
|
2015
Q4 | $197K | Sell |
6,441
-285
| -4% | -$8.97K | 0.14% | 102 |
|
|
2015
Q3 | $200K | Sell |
6,726
-1,947
| -22% | -$62.4K | 0.16% | 102 |
|
|
2015
Q2 | $276K | Sell |
8,673
-1,119
| -11% | -$36.5K | 0.19% | 85 |
|
|
2015
Q1 | $323K | Sell |
9,792
-507
| -5% | -$16.1K | 0.24% | 74 |
|
|
2014
Q4 | $304K | Sell |
10,299
-582
| -5% | -$16.7K | 0.22% | 77 |
|
|
2014
Q3 | $305K | Buy |
10,881
+814
| +8% | +$22.8K | 0.23% | 75 |
|
|
2014
Q2 | $283K | Sell |
10,067
-641
| -6% | -$18.3K | 0.22% | 84 |
|
|
2014
Q1 | $326K | Sell |
10,708
-149
| -1% | -$4.44K | 0.27% | 70 |
|
|
2013
Q4 | $316K | Buy |
+10,857
| New | +$316K | 0.26% | 71 |
|
Other funds holding PFE
Tradewinds Capital Management's PFE Position: Q2 2026 in Review
Tradewinds Capital Management held its Pfizer (PFE) position steady in Q2 2026 at 1,976 shares worth $47.6K. The position accounts for 0.01% of the portfolio, ranked #225.
Tradewinds Capital Management first reported a position in PFE in Q4 2013 and has held it in 51 quarters since. The position peaked at $414K in Q4 2021. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Tradewinds Capital Management held 1,976 shares of Pfizer worth $47.6K as of Q2 2026.
- Tradewinds Capital Management left its Pfizer share count unchanged in Q2 2026.
- Pfizer made up 0.01% of Tradewinds Capital Management's portfolio in Q2 2026, its #225 holding.
- Tradewinds Capital Management first reported a position in Pfizer in Q4 2013 and has held it in 51 quarters since.
- Tradewinds Capital Management's Pfizer position peaked at $414K in Q4 2021.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.